LINC01410 is notably overexpressed in various malignancies, including papillary thyroid carcinoma, endometrial carcinoma, cholangiocarcinoma, neuroblastoma, bladder cancer, gallbladder cancer, cervical carcinoma, and osteosarcoma. Here, LINC01410 is linked to osteosarcoma.